Evidence map›Paper›PMID 41821109›Full record

ArticleBMC pharmacology & toxicology2026

In vitro comparative quality evaluation of different brands of metformin hydrochloride tablets available in Mekelle City, Tigray Regional State, Ethiopia.

Brhane Gebrehiwot Welegebrial, Zenawi Gezae, Samrawit Kidanemariam Gebrekidan, Gebru Gebremeskel Gebrerufael, Haylay Araya Gebregzabiher, Abrahaley Mulu Kidane, Gebretekle Gebremichael Hailesilase

Abstract readComparative Study
In one paragraph

Article in BMC pharmacology & toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Brhane Gebrehiwot WelegebrialFaculty of Pharmacy, College of Health Sciences, Mekelle University, Mekelle, Ethiopia. brhanegb008@gmail.com.ORCID http://orcid.org/0000-0003-3600-7477
Zenawi GezaeDepartment of Pharmacy, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia.
Samrawit Kidanemariam GebrekidanDepartment of Pharmacy, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia.
Gebru Gebremeskel GebrerufaelDepartment of Statistics, College of Natural and Computational Sciences, Adigrat University, Adigrat, Ethiopia.ORCID http://orcid.org/0000-0003-2795-8529
Haylay Araya GebregzabiherDepartment of Pharmacy, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia.ORCID http://orcid.org/0000-0003-2467-9866
Abrahaley Mulu KidaneDepartment of Pharmacy, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia.
Gebretekle Gebremichael HailesilaseDepartment of Pharmacy, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia.ORCID http://orcid.org/0000-0003-2211-3308

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdministration of poor-quality medications can result in various effects that jeopardize the drugs’ safety and effectiveness. Due to a lack of adequate post-market surveillance studies, making decisions regarding the quality of medicines, including metformin hydrochloride tablets, available in Mekelle City is challenging. Thus, the aim of the study was to evaluate the quality of different brands of metformin hydrochloride tablets sold in Mekelle City, Tigray Regional State, Ethiopia.

methodsA total of eight brands of 500 mg metformin hydrochloride tablets were collected from drug retail outlets in Mekelle City. In vitro quality control tests were conducted based on the WHO visual inspection tool and United States Pharmacopeia (USP) specifications. These included visual inspection, weight variation, thickness, hardness, friability, disintegration time, dissolution, and an assay of active ingredient. One-way ANOVA was used to compare all parameters of quality control. A difference was deemed statistically significant when P < 0.05. One-way ANOVA, model-independent approaches, and model-dependent approaches were used to compare the dissolution profiles and to determine the nature of active pharmaceutical ingredient release.

resultsThis study showed that all metformin hydrochloride brands marketed in Mekelle City complied with the WHO visual inspection and USP specifications for visual inspection, weight variation, friability, disintegration time, and assay of the active ingredient. Of the samples tested, brand E and brand F exhibited the highest and lowest hardness values, respectively, at 313.88 N and 10.06 N. Moreover, all eight brands evaluated released more than 80% of their drug contents within 30 min as outlined in the USP. However, the difference factor (f1) and similarity factor (f2) have indicated that only brands A, E, and H were similar (can be used interchangeably) with the comparator product. Weibull release model suits the drug release data, which had the highest correlation coefficient.

conclusionsAll brands met pharmacopoeial specifications, but significant variations in hardness and dissolution profiles were observed, with only three brands showing profile similarity to the comparator. Hence, the finding serves as an alert to examine the dossier evaluations and legal approval processes of the Ethiopian Food and Drug Authority.

Indexed as

Hypoglycemic AgentsMetforminBulk DrugsEthiopiaHardnessQuality ControlSolubilityTabletsBulk DrugsHypoglycemic AgentsMetforminTabletsDissolution profileEthiopiaHardness testMekelleMetformin hydrochloride

Identifiers

PMID41821109
PMCPMC13093923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.